KRYS Form 144: Janney reports two proposed sales

KRYS filing a Form 144 notice reports proposed sales of common stock by Daniel S. Janney.

Rhea-AI Filing Summary

KRYS filing a Form 144 notice reports proposed sales of common stock by Daniel S. Janney. The filing lists a proposed sale of 37,895 shares for $10,113,354.42 and a proposed sale of 13,825 shares for $3,709,850.15, both dated 02/24/2026.

Insights

Securities Compliance Analyst

Form 144 records proposed insider sales with exact share counts and proceeds.

These entries show two proposed dispositions by Daniel S. Janney on 02/24/2026: 37,895 shares at $10,113,354.42 and 13,825 shares at $3,709,850.15. Form 144 is a regulatory notice required before certain public sales.

Filing of Form 144 does not confirm that the shares were sold; it signals the holder's intent to sell under applicable resale rules. Subsequent SEC reports or a broker report would show execution details.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does KRYS Form 144 show about Daniel S. Janney?

Answer: The Form 144 lists two proposed sales by Daniel S. Janney: 37,895 shares for $10,113,354.42 and 13,825 shares for $3,709,850.15, both dated 02/24/2026. This is a regulatory notice of intent to sell.

Does Form 144 mean the shares were sold for KRYS?

Answer: No; Form 144 is a notice of proposed sale required before certain public dispositions. The filing lists proposed share counts and proceeds but does not by itself confirm that the transactions executed.

How many shares and proceeds are reported in the filing?

Answer: The filing reports a proposed sale of 37,895 shares for $10,113,354.42 and 13,825 shares for $3,709,850.15, with both entries dated 02/24/2026.

Where can execution details appear after a Form 144?

Answer: Execution details typically appear in broker reports or subsequent SEC filings confirming sale completion. The Form 144 itself is the pre-sale notice and does not supply trade confirmation or settlement information.

Who is the reporting person in this KRYS filing?

Answer: The reporting person listed is Daniel S. Janney, with an address noted as 2100 Wharton Street Suite 701, Pittsburgh, PA 15203, associated with the two proposed sales dated 02/24/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/25/2026 - 04:38 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001198325
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Krystal Biotech, Inc
SEC File Number	001-38210
Address of Issuer	2100 Wharton Street Suite 701 Pittsburgh PENNSYLVANIA 15203
Phone	4125865830
Name of Person for Whose Account the Securities are To Be Sold	Daniel S Janney
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 555 California Street STE 1800 San Francisco CA 94104	700	192500	29232189	02/25/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/25/2017	Private Placement	Issuer			700	08/25/2017	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Daniel S Janney 2100 Wharton Street Suite 701 Pittsburgh PA 15203	Common	02/24/2026	37895	10113354.42
Daniel S Janney 2100 Wharton Street Suite 701 Pittsburgh PA 15203	Common	02/24/2026	13825	3709850.15

144: Remarks and Signature

Remarks	Shares sold via Alta Bioequities LP
Date of Notice	02/25/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/25/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Daniel S Janney
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)